PCM
SWAV

Prelude Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Prelude Capital Management’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,268
Closed -$1.39M – 1575
2024
Q1 		$1.39M Sell
4,268
-2,252
-35% -$553K 0.07% 320
2023
Q4 		$1.24M Buy
6,520
+2,498
+62% +$472K 0.08% 254
2023
Q3 		$801K Buy
4,022
+2,032
+102% +$481K 0.05% 350
2023
Q2 		$568K Sell
1,990
-4,338
-69% -$1.2M 0.04% 421
2023
Q1 		$1.37M Buy
6,328
+2,583
+69% +$503K 0.08% 269
2022
Q4 		$770K Buy
3,745
+225
+6% +$56.9K 0.04% 435
2022
Q3 		$979K Sell
3,520
-1,619
-32% -$412K 0.04% 438
2022
Q2 		$982K Sell
5,139
-5,437
-51% -$960K 0.03% 534
2022
Q1 		$2.19M Buy
+10,576
New +$1.74M 0.06% 308
2020
Q1 		– Sell
-46
Closed -$2K – 2153
2019
Q4 		$2K Buy
+46
New +$1.7K ﹤0.01% 1839

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Prelude Capital Management's SWAV Position: Q2 2024 in Review

Prelude Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 4,268 shares — an estimated $1.39M sold.

Prelude Capital Management first reported a position in SWAV in Q4 2019 and held it in 10 quarters. The position peaked at $2.19M in Q1 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Prelude Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Prelude Capital Management sold 4,268 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.39M.
  • Prelude Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
  • Prelude Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $2.19M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.